All In Biotech

Drug Trial Radar · NCT00832039

Placebo Controlled Trial of Sodium Selenite and Procalcitonin Guided Antimicrobial Therapy in Severe Sepsis

Prospective, Randomized Multicenter Trial of Adjunctive Intravenous Therapy With Sodium-selenite(Selenase®, Double-blinded) and a Procalcitonin Guided Causal Therapy (Open) of Severe Sepsis or Septic Shock.

Last checked: Nov 20, 2026Latest source record: Aug 12, 2016 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 1,089 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

1,089

Actual

Start

Nov 2009

Primary completion

Mar 2013

Study completion Jun 2013

Sponsor

Lead sponsor
Kompetenznetz SepsisResearch network
Sponsor type
Research network
Collaborators
Biosyn; Brahms AG
First posted
Jan 29, 2009

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Factorial
Masking
Double (participant, investigator)
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Severe sepsis and septic shock are diseases of infectious origin with a high risk of death. The purpose of this study is to determine whether the intravenous application of selenium (given as sodium-selenite) can reduce mortality in patients with severe sepsis or septic shock. Additionally, it is investigated, whether the measurement of procalcitonin - a marker of infection - can be used to guide anti-infectious measures in this disease.

Conditions

  • Severe Sepsis
  • Septic Shock

Interventions

  • sodium-seleniteDrug

    An intravenous bolus of 1000 µg followed by a continuous intravenous infusion of 1000 µg/day until patient is discharged from the ICU but not more than 21 applications à 24 hours.

  • PlaceboDrug

    An intravenous bolus of placebo followed by a continuous intravenous infusion with placebo until patient is discharged from the ICU but not more than 21 applications à 24 hours.

  • Procalcitonin guided therapyProcedure

    Causal therapy of sepsis is guided by applying the following algorithm: Day 4: PCT drop from baseline \>=50%: no change in causal therapy; PCT drop from baseline \<50%: change or optimize antimicrobial therapy, new intervention (i.e. surgery, diagnostics) recommended for source control. Day 7, 10, 14: PCT \<=1.0 ng/ml: finish antimicrobial therapy; PCT \>1.0 ng/ml and PCT drop from last PCT measurement \>=50%: finish antimicrobial therapy; PCT \>1.0 ng/ml and PCT drop from last PCT measurement \<50%: change or optimize antimicrobial therapy, new intervention (i.e. surgery, diagnostics) recommended for source control.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. All cause mortalityTime frame: 28 days

Locations

35 sites in 1 country. Site status is shown where the registry gives one.

  • University Hospital Aachen - Dep. of Intensive Care Medicine

    Aachen, Germany

  • Klinikum Augsburg - Dep. of Anesthesiology and Intensive Care Medicine

    Augsburg, Germany

  • Klinikum Augsburg - Dep. of Medicine I

    Augsburg, Germany

  • Military Hospital Berlin - Dep. of Anaesthesiology and Intensive Care Medicine

    Berlin, Germany

  • Charité Berlin - Dep. of Anesthesiology and Intensive Care Medicine

    Berlin, Germany

  • Vivantes Klinikum Neukölln - Dep. of Anesthesiology, Intensive Care Medicine and Pain Therapy

    Berlin, Germany

  • DRK-Kliniken Berlin-Köpenick - Dep. of Anesthesiology, Pain Therapy, and Intensive Care Medicine

    Berlin, Germany

  • Charité Berlin - Campus Virchow-Klinikum - Dep. of Nephrology

    Berlin, Germany

  • Ev. Krankenhaus Gilead - Dep. of Anesthesiology

    Bielefeld, Germany

  • University Hospital Bonn - Dep. of Anesthesiology and Intensive Care Medicine

    Bonn, Germany

  • University Hospital Köln - Dep. of Medicine I

    Cologne, Germany

  • Krankenhaus Dresden-Friedrichstadt

    Dresden, Germany

  • University Hospital Dresden - Dep. of Anesthesiology and Intensive Care Med.

    Dresden, Germany

  • HELIOS Klinikum Erfurt - Dep. of Anesthesiology and Intensive Care Medicine

    Erfurt, Germany

  • University Erlangen-Nürnberg - Dep. of Medicine IV

    Erlangen, Germany

  • J.-W. Goethe University Hospital - Dep. of Anaesthesiology, Intensive Care Medicine and Pain Therapy

    Frankfurt am Main, Germany

  • University Hospital Freiburg- Dep. of Surgery

    Freiburg im Breisgau, Germany

  • Georg August Universität Göttingen - Dep. of Anesthesiology and Intensive Care Medicine

    Göttingen, Germany

  • Ernst-Moritz-Arndt-Universität Greifswald - Dep. of Anesthesiology and Intensive Care Medicine

    Greifswald, Germany

  • Martin-Luther-Universität Halle-Wittenberg - Dep. of Anesthesiology

    Halle, Germany

  • University Hospital Halle - Dep. of Medicine III

    Halle, Germany

  • Universitätsklinikum Hamburg-Eppendorf - Dep. of Intensive Care Medicine

    Hamburg, Germany

  • Westküstenklinikum Heide - Dep. of Anesthesiology and Intensive Care Medicine

    Heide, Germany

  • University Hospital Heidelberg - study center Anesthesiology/Surgery

    Heidelberg, Germany

  • University Hospital Jena, Dep. of Anesthesiology and Intensive Care Medicine

    Jena, Germany

  • University Hospital Kiel - Dep. of. Anesthesiology and Intensive Care Medicine

    Kiel, Germany

  • St. Elisabeth-Krankenhaus - Dep. of Anesthesiology

    Köln-Hohenlind, Germany

  • University Hospital Leipzig - Dep. of Anesthesiology and Intensive Care Medicine

    Leipzig, Germany

  • University Hospital Mannheim - Dep. of Medicine I

    Mannheim, Germany

  • Krankenhaus München-Neuperlach - Dep. of Anesthesiology

    München, Germany

  • University Hospital Munich - Dep. of Internal Medicine

    Munich, Germany

  • University Hospital Munich - Dep. of Anaesthesiology

    Munich, Germany

  • Hospital Munich Harlaching - Dep. of Internal Acute Medicine and Prevention

    Munich, Germany

  • University Hospital Münster - Dep. of Anesthesiology and Intensive Care Medicine

    Münster, Germany

  • Klinikum Oldenburg GmbH - Dep. of Anesthesiology

    Oldenburg, Germany

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.